Boston Scientific Corporation
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IE
US
US
US
US
IN
US
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Track Boston Scientific Corporation in real time with a live news feed covering Boston Scientific Corporation stock news, official press releases, company announcements, and an archive of historical Boston Scientific Corporation news. ...more
Loading news...
Loading more...
Sign in to download news snippet
AU, APTV and BSX have been added to the Zacks Rank #5 (Strong Sell) List on August 28th, 2026.
Read full articleNo data available for this time period.
Change the time range to see results.
AU, APTV and BSX have been added to the Zacks Rank #5 (Strong Sell) List on August 28th, 2026.
Read full article
On Aug. 26, 2026, a cyberattack halted order processing and shipping at the medical device maker, leaving investors uncertain about the speed of recovery and near-term shipment delays.
Read full article
Boston Scientific's stock is sliding in the wake of a major cyberattack, adding to its recent woes.
Read full article
A cyberattack on U.S. medical device maker Boston Scientific is causing an ongoing “global disruption” to its operations, according to a federal regulatory filing on Wednesday, the latest healthtech giant to face a cyberattack in recent weeks.
Read full article
On Tuesday, Boston Scientific Corporation (NYSE:BSX) identified a cybersecurity incident on Tuesday that caused global operational disruptions, including delays in processing and shipping customer orders.
Read full article
Boston Scientific said its global operations were disrupted by a "cybersecurity incident." The company also admitted its investigation was ongoing and the nature, scope, and impact of the incident had yet to be determined.
Read full article
Boston Scientific stock falls as the medical device maker announces the latest batch of bad news for the company.
Read full article
Boston Scientific was hit with a cyberattack that is affecting its operations, the company said Wednesday in an SEC filing. The attack is continuing to disrupt the company's ability to ship products, and it's not clear when services will be restored.
Read full article
Boston Scientific said on Wednesday that a cybersecurity incident had disrupted global operations, including some information systems used to process and ship customer orders.
Read full article
Boston Scientific stock falls as the medical device maker announces the latest batch of bad news for the company.
Read full article
Boston Scientific was hit with a cyberattack that is affecting its operations, the company said Wednesday in an SEC filing. The attack is continuing to disrupt the company's ability to ship products, and it's not clear when services will be restored.
Read full article
Boston Scientific said on Wednesday that a cybersecurity incident had disrupted global operations, including some information systems used to process and ship customer orders.
Read full article
Callan Family Office LLC bought a new position in shares of Boston Scientific Corporation (NYSE: BSX) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 52,745 shares of the medical equipment provider's stock, valued at approximately $2,251,000. Other large investors also recently
Read full article
Asahi Life Asset Management CO. LTD. bought a new position in Boston Scientific Corporation (NYSE: BSX) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 10,155 shares of the medical equipment provider's stock, valued at approximately $433,000. A
Read full article
Aurora Investment Counsel bought a new position in Boston Scientific Corporation (NYSE: BSX) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 43,857 shares of the medical equipment provider's stock, valued at approximately $1,872,000. A number of other institutional investors have also recently
Read full article
Boston Scientific has corrected sharply due to EP and WATCHMAN slowdowns, but 74% of its portfolio continues healthy growth. Weakness in BSX's EP business appears addressable with new product launches like FARAWAVE Ultra and ICE, expected to drive recovery from 2H 2027 onward. Valuation is compelling: BSX trades at 15.27x forward earnings, a significant discount to peers and historical averages, despite resilient core businesses.
Read full article
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read full article
B. Riley Wealth Advisors Inc. reduced its stake in Boston Scientific Corporation (NYSE: BSX) by 56.1% during the undefined quarter, according to the company in its most recent filing with the SEC. The fund owned 8,467 shares of the medical equipment provider's stock after selling 10,822 shares during the quarter.
B. Riley Wealth
E. Ohman J or Asset Management AB cut its holdings in Boston Scientific Corporation (NYSE: BSX) by 91.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 51,275 shares of the medical equipment provider's stock after selling 541,890 shares during the
Read full article
No data available for this time period.
Change the time range to see results.